SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 16th, 2021 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 12, 2021, between Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SERIES A COMMON STOCK PURCHASE WARRANT CALADRIUS BIOCIENCES, INC.Warrant Agreement • February 16th, 2021 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 17, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIAL Caladrius Biosciences, Inc.Exclusive Agency Agreement • February 16th, 2021 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
